Seizure management in acute hepatic porphyria: risks of valproate and clonazepam.
about
Diagnosis and management of porphyriaA comparative study of the relative enzyme inducing properties of anticonvulsant drugs in epileptic patientsAcute Hepatic PorphyriaAcute intermittent porphyria and epilepsy: safety of clonazepamAcute intermittent porphyria: pathophysiology and treatment.Acute intermittent porphyria presenting as epilepsyEffect of anticonvulsant drugs on serum delta-aminolaevulinic acid levels in non-porphyric subjects.An elusive case of acute abdomenConversion of 5-aminolaevulinate into haem by homogenates of human liver. Comparison with rat and chick-embryo liver homogenates.Oxcarbazepine in focal epilepsy and hepatic porphyria: a case report.Microsomal enzyme induction and clinical aggravation of porphyria: the evaluation of human urinary 6beta-hydroxycortisol/cortisol ratio as the index of hepatic CYP3A4 activity.Epidemiology and clinical characteristics of seizures in patients with acute intermittent porphyria.Levetiracetam in focal epilepsy and hepatic porphyria: a case report.Acute intermittent porphyria presenting as a diffuse encephalopathy.Acute intermittent porphyria: a diagnostic challenge.Treatment of porphyric convulsions with magnesium sulfate.Pathogenesis and treatment of acute intermittent porphyria: discussion paper.Levetiracetam in Idiopathic Generalised Epilepsy and Porphyria??Cutanea Tarda
P2860
Q24527280-E5253B92-72F0-4CD8-8376-22436B199843Q24544077-82D35303-8B5E-452A-8544-7404358FAF8FQ26781776-563A8BA2-4A04-4103-A20A-F1948C5BF0EAQ28324495-503C4035-BEB6-4354-AA44-BF8FDB2A2352Q40180941-96C62057-4592-4696-BB37-C9DC9DB8CC91Q41842295-4DB7B22A-ACAE-461C-AC83-9681808A1650Q42100519-FBBEE0D7-E10E-4204-BBD0-ED8EE58EC42DQ42535584-B4279129-9610-42A3-BF26-A760B13C6C0FQ42849557-3D90A390-1160-4835-9A5D-5CD1D4285054Q43650822-52A47693-E2DE-443B-BCC0-B5BC4260E81FQ44237138-C34B8E23-9F20-4BD5-9BB4-A3840E6AB731Q44546364-A61B229F-1376-4B9D-BF88-23E39AFAE252Q44854315-1BB0D320-0EAE-43C9-B76F-820EAF63F5E5Q46399758-C1810BEC-DBDE-4EAE-960E-5CB5E1333B52Q48761488-0AA80D53-B933-41AE-9ACF-9763DB879C35Q51706544-3968DD0E-E23A-4842-B9CC-207D2FDF29F9Q55075935-227A8376-A6CC-42AF-99EA-4E6907A6606BQ57991899-FFDC4440-79D9-4F1E-912D-8F4B99F90777
P2860
Seizure management in acute hepatic porphyria: risks of valproate and clonazepam.
description
1980 nî lūn-bûn
@nan
1980 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1980 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1980年の論文
@ja
1980年論文
@yue
1980年論文
@zh-hant
1980年論文
@zh-hk
1980年論文
@zh-mo
1980年論文
@zh-tw
1980年论文
@wuu
name
Seizure management in acute hepatic porphyria: risks of valproate and clonazepam.
@ast
Seizure management in acute hepatic porphyria: risks of valproate and clonazepam.
@en
Seizure management in acute hepatic porphyria: risks of valproate and clonazepam.
@nl
type
label
Seizure management in acute hepatic porphyria: risks of valproate and clonazepam.
@ast
Seizure management in acute hepatic porphyria: risks of valproate and clonazepam.
@en
Seizure management in acute hepatic porphyria: risks of valproate and clonazepam.
@nl
prefLabel
Seizure management in acute hepatic porphyria: risks of valproate and clonazepam.
@ast
Seizure management in acute hepatic porphyria: risks of valproate and clonazepam.
@en
Seizure management in acute hepatic porphyria: risks of valproate and clonazepam.
@nl
P2093
P356
P1433
P1476
Seizure management in acute hepatic porphyria: risks of valproate and clonazepam.
@en
P2093
Bonkowsky HL
Sinclair JF
Sinclair PR
P304
P356
10.1212/WNL.30.6.588
P407
P577
1980-06-01T00:00:00Z